Please use this identifier to cite or link to this item:
https://doi.org/10.1002/ajh.23731
DC Field | Value | |
---|---|---|
dc.title | Clinical profiles of multiple myeloma in asia-an asian myeloma network study | |
dc.contributor.author | Kim, K. | |
dc.contributor.author | Lee, J.H. | |
dc.contributor.author | Kim, J.S. | |
dc.contributor.author | Min, C.K. | |
dc.contributor.author | Yoon, S.S. | |
dc.contributor.author | Shimizu, K. | |
dc.contributor.author | Chou, T. | |
dc.contributor.author | Kosugi, H. | |
dc.contributor.author | Suzuki, K. | |
dc.contributor.author | Chen, W. | |
dc.contributor.author | Hou, J. | |
dc.contributor.author | Lu, J. | |
dc.contributor.author | Huang, X.-J. | |
dc.contributor.author | Huang, S.-Y. | |
dc.contributor.author | Chng, W.J. | |
dc.contributor.author | Tan, D. | |
dc.contributor.author | Teoh, G. | |
dc.contributor.author | Chim, C.S. | |
dc.contributor.author | Nawarawong, W. | |
dc.contributor.author | Siritanaratkul, N. | |
dc.contributor.author | Durie, B.G. | |
dc.date.accessioned | 2016-09-06T08:42:32Z | |
dc.date.available | 2016-09-06T08:42:32Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Kim, K., Lee, J.H., Kim, J.S., Min, C.K., Yoon, S.S., Shimizu, K., Chou, T., Kosugi, H., Suzuki, K., Chen, W., Hou, J., Lu, J., Huang, X.-J., Huang, S.-Y., Chng, W.J., Tan, D., Teoh, G., Chim, C.S., Nawarawong, W., Siritanaratkul, N., Durie, B.G. (2014). Clinical profiles of multiple myeloma in asia-an asian myeloma network study. American Journal of Hematology 89 (7) : 751-756. ScholarBank@NUS Repository. https://doi.org/10.1002/ajh.23731 | |
dc.identifier.issn | 03618609 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/126879 | |
dc.description.abstract | The incidence of multiple myeloma (MM) is known to be variable according to ethnicity. However, the differences in clinical characteristics between ethnic groups are not well-defined. In Asian countries, although the incidence of MM has been lower than that of Western countries, there is growing evidence that MM is increasing rapidly. The Asian Myeloma Network decided to initiate the first multinational project to describe the clinical characteristics of MM and the clinical practices in Asia. Data were retrospectively collected from 23 centers in 7 countries and regions. The clinical characteristics at diagnosis, survival rates and initial treatment of 3,405 symptomatic MM patients were described. Median age was 62 years (range, 19-106), with 55.6% of being male. Median overall survival (OS) was 47 months (95% CI 44.0-50.0). Stem cell transplantation was performed in 666 patients who showed better survival rates (79 vs. 41 months, P | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1002/ajh.23731 | |
dc.source | Scopus | |
dc.type | Article | |
dc.contributor.department | MEDICINE | |
dc.description.doi | 10.1002/ajh.23731 | |
dc.description.sourcetitle | American Journal of Hematology | |
dc.description.volume | 89 | |
dc.description.issue | 7 | |
dc.description.page | 751-756 | |
dc.description.coden | AJHED | |
dc.identifier.isiut | 000338029300014 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.